Migraines & Headaches
ProEthic announces positive trial results for fast-acting migraine candidate
Published in Medical Letter on the CDC and FDA, February 11th, 2007
These findings will serve as the basis for a New Drug Application (NDA) for PRO-513, expected to be filed with the U.S. Food and Drug Administration in early 2007.
In an eight month randomized, double-blind, placebo-controlled trial that enrolled 690 adult patients, PRO-513, a proprietary formulation of diclofenac potassium powder for oral solution, reached all of its primary endpoints by achieving statistical superiority to placebo in pain relief (p greater than 0.001) and the associated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Life Sciences
New life sciences findings from Center for Drug Evaluation and Research published - Muscular Dystrophy Therapy
Findings from Ohio State University, Columbus Children's Research Institute provide new insights into muscular dystrophy therapy - Rehabilitation Research
Investigators at Quinnipiac University, Department of Physical Therapy target rehabilitation research - Acute Myeloid Leukemia
Xanthus receives orphan drug designation of Xanafide for treating acute myeloid leukemia - Acute Radiation Syndrome
U.S. FDA clears Humanetics' IND filing to commence clinical studies on new radiation countermeasure - Business & Finance
Critical Therapeutics reports preliminary operating results for fourth quarter of 2006 - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
